Pediatric Delirium

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

April 5, 2026

Study Completion Date

April 5, 2026

Conditions
Pediatric Delirium
Interventions
DRUG

Intra-nasal Dexmedetomidine

Subjects will receive Dexmedetomidine intra-nasally in the preoperative area. It will be administered at a dose of 1 mcg/kg, approximately 15-25 minutes before entering the operating room.

DRUG

Oral Midazolam

Subjects will receive Midazolam orally in the preoperative area. It will be administered at a dose of 0.5 mg/kg (with a maximum dose of 20 mg), approximately 10-15 minutes before entering the operating room.

Trial Locations (1)

01655

University of Massachusetts Medical School, Worcester

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER